ArticleJournal of orthopaedic case reports2026
The Effect of Intraarticular Platelet-Rich Plasma Injection in Knee Osteoarthritis.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Knee osteoarthritis (KOA) is a prevalent degenerative joint disorder with progressive cartilage loss, chronic pain, and functional limitation. Platelet-rich plasma (PRP), an autologous concentrate with growth factors, has gained attention as a therapeutic modality due to its regenerative and anti-inflammatory properties. This study evaluated clinical, biochemical, and radiological outcomes of intra-articular PRP injections in KOA patients. Materials and Methods: This randomized controlled trial spanned over 18 months at a tertiary care center. A total of 70 patients with Kellgren-Lawrence grade II and III KOA were randomly allocated into the PRP group (n = 35) and normal saline (NS) group (n = 35). Baseline assessment included Visual Analog Scale (VAS) index, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) functional index, serum Coll2-1 levels, and whole-organ magnetic resonance imaging score (WORMS). Patients received ultrasound (USG)-guided intra-articular injections at baseline and 1 month. Follow-up evaluations were performed at 1, 3, 6, and 9 months. Statistical analysis was done using appropriate parametric and non-parametric tests. Results: Baseline characteristics were comparable between groups. The PRP group demonstrated significant reduction in WOMAC and VAS scores from 1 month onward, with sustained improvement at 3, 6, and 9 months versus the NS group (P < 0.05). Magnetic resonance imaging showed significant reduction in WORMS scores in the PRP group, whereas no significant change was observed in the NS group. In addition, serum Coll2-1 levels significantly decreased in the PRP group at 9 months, indicating reduced cartilage degradation. Conclusion: Intra-articular PRP injections significantly improved pain, functional outcomes, and structural parameters in patients with moderate KOA. These findings suggest that PRP may serve as an effective therapeutic option with potential disease-modifying benefits in the management of KOA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.